HIGHLIGHTS
SUMMARY
Hypercalcemia is associated with different neoplasms, may occur in up to 20-30% of all cancer patients, and is related to a poor prognosis. Constipation is the least frequent gastrointestinal symptom, complained about by only 9.4% of patients. Regarding medical therapy, somatostatin analogues (SSAs) were used in 37.9% of patients, chemotherapy was employed in 32.6% of patients, peptide receptor radionuclide therapy (PRRT) was administered in 10.5% patients, and target therapy with sunitinib and everolimus were both employed in five cases. This observation is particularly interesting if the authors consider that . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.